https://twitter.com/Foothills_FTXP/status/139...6903329795
$FTXP U.S. #NaturalGas EIA data for this week generates a
https://twitter.com/Foothills_FTXP/status/139...6903329795
Top 10 Most Recent News Articles
Step Inside Henson's Creature Shop Magic in NYC
Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...
Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled
AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...
Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band
They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...
Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling
Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...
Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare
A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...
Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks
Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...
Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport
Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...
Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime
Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...
Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?
Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...
Continue ReadingTop 5 Most Recently Viewed Articles
Investing in Dell Technologies: A Remarkable Growth Story
Investing in Dell Technologies: A Remarkable Growth Story Dell Technologies (NYSE: DELL) has shown impressive performance over the past five years, significantly surpassing market averages. With an annualized growth rate of 16.74%, investors have reaped substantial rewards from the company’s strong strategy and execution, resulting in an average annual return of 29.36%....
Continue Reading
SoundExchange Highlights 2025's Musical Achievements and Trends
Looking Back at 2025: Top Tracks and Emerging Talents As the year comes to a close, SoundExchange has unveiled its annual compilation of the Top Tracks and Breakout Creators for 2025. The selection showcases an exciting array of artists, highlighting the most streamed songs and rapidly rising musicians over the past year, fueled by a remarkable digital music landscape....
Continue Reading
ClimateTech Connect: Pioneering a Green Future in Washington
ClimateTech Connect Conference Overview ClimateTech Connect is set to revolutionize the discourse around climate resilience and innovation with its upcoming global conference in Washington, DC. This unique event, scheduled for April 15-16, 2025, is designed to unite thought leaders, innovators, policymakers, and industry experts. The aim is to delve into the fusion of...
Continue Reading
Laminar Pharma Shows Promising Results for LAM561 in Glioblastoma
Laminar Pharma's Positive Clinical Trial Results Laminar Pharma has recently disclosed encouraging updates regarding its clinical trial evaluating LAM561, an innovative cancer treatment for newly diagnosed glioblastoma patients. This clinical trial is focused particularly on those with MGMT-methylated tumors, a common prognostic factor in this aggressive form of brain...
Continue Reading
FTC Solar Set to Reveal Q4 and Yearly Financial Results Soon
FTC Solar to Report Financial Results FTC Solar, Inc. (Nasdaq: FTCI), renowned as a top-tier provider of solar tracker systems and engineering services, has shared plans to announce its financial outcomes for the fourth quarter and the entire year of 2024. This important announcement will occur prior to market opening on a Monday. Details of the Announcement On the day of...
Continue Reading